California-based medical robotics startup Mendaera, has secured $73 million series B funding round to finalize robotic technology development, fuel AI and connectivity capabilities, and deploy the robotic system for real-world trials in clinical setups.
Co-founded in 2020 by Joshua DeFonzo and Jason Wilson, the company aims to integrate medical robotics into interventional radiology. The med tech startup is working to commercialize its AI-driven handheld interventional platform to improve patient care.
According to the company’s announcement, the latest funding round was backed by Threshold Ventures, PFM Health Sciences, Lux Capital, and founder of Intuitive Surgical and Auris Health, Fred Moll.
Robotic Platform for Interventional Procedures
Mendaera’s platform was designed to help healthcare organizations handle the surging demand for interventional procedures during provider shortages.
It integrates robotic, virtual connectivity, and imaging capabilities to help healthcare entities provide commonplace medical procedures such as biopsies, pain management, and vascular and organ access interventions.
AI-powered product is designed to be deployed across multiple sites of service and medical specialties to improve patient access to life-saving needle-based interventional care.
Last December, Mendaera signed a collaborative deal with a leading ultrasound maker, Butterfly Network, to integrate the two technologies to increase access to interventional care.
